ZA796896B - Pharmaceutical composition having antitumor activity - Google Patents
Pharmaceutical composition having antitumor activityInfo
- Publication number
- ZA796896B ZA796896B ZA00796896A ZA796896A ZA796896B ZA 796896 B ZA796896 B ZA 796896B ZA 00796896 A ZA00796896 A ZA 00796896A ZA 796896 A ZA796896 A ZA 796896A ZA 796896 B ZA796896 B ZA 796896B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- antitumor activity
- antitumor
- activity
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
- A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/813—Carrier is a saccharide
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16138878A JPS5592325A (en) | 1978-12-29 | 1978-12-29 | Antitumor agent and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA796896B true ZA796896B (en) | 1980-11-26 |
Family
ID=15734135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00796896A ZA796896B (en) | 1978-12-29 | 1979-12-19 | Pharmaceutical composition having antitumor activity |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS5592325A (xx) |
AU (1) | AU518952B2 (xx) |
BE (1) | BE880970A (xx) |
ZA (1) | ZA796896B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5665828A (en) * | 1979-11-02 | 1981-06-03 | Kureha Chem Ind Co Ltd | Antitumor agent |
JPS58118520A (ja) * | 1982-01-09 | 1983-07-14 | Hidematsu Hirai | 抗腫瘍性蛋白複合体およびその製造法 |
US4448663A (en) * | 1982-07-06 | 1984-05-15 | The Dow Chemical Company | Double L-shaped electrode for brine electrolysis cell |
JPH0651643B2 (ja) * | 1983-01-19 | 1994-07-06 | 帝人株式会社 | 殺細胞性修飾免疫グロブリン及びその製造方法 |
JPH0611713B2 (ja) * | 1983-04-08 | 1994-02-16 | 呉羽化学工業株式会社 | ヒト免疫グロブリン結合抗腫瘍剤 |
JPS6041617A (ja) * | 1983-08-18 | 1985-03-05 | Teijin Ltd | 殺細胞性修飾免疫グロブリン及びその製造法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS162953B1 (xx) * | 1972-05-10 | 1975-07-31 | ||
GB1509707A (en) * | 1974-09-20 | 1978-05-04 | Searle & Co | Immunological compounds |
IL47372A (en) * | 1975-05-27 | 1979-10-31 | Yeda Res & Dev | Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same |
-
1978
- 1978-12-29 JP JP16138878A patent/JPS5592325A/ja active Granted
-
1979
- 1979-12-19 ZA ZA00796896A patent/ZA796896B/xx unknown
- 1979-12-21 AU AU54144/79A patent/AU518952B2/en not_active Ceased
- 1979-12-28 BE BE6/47054A patent/BE880970A/fr not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU518952B2 (en) | 1981-10-29 |
JPS6254086B2 (xx) | 1987-11-13 |
JPS5592325A (en) | 1980-07-12 |
AU5414479A (en) | 1980-07-03 |
BE880970A (fr) | 1980-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH16902A (en) | Pharmaceutical composition having anti-tumor activity | |
GB2039738B (en) | Inflammation - preventing pharmaceutical composition | |
JPS52114026A (en) | Pharmaceutical composition having antiiinflammation activity | |
JPS53113007A (en) | Pharmaceutical composition | |
JPS53109934A (en) | Pharmaceutical composition | |
JPS54132223A (en) | Novel pharmaceutical composition | |
GB2003028B (en) | Pharmaceutical compositions | |
JPS5484022A (en) | Pharmaceutical composition | |
JPS53133637A (en) | Pharmaceutical composition | |
JPS5449333A (en) | Pharmaceutical composition | |
PH15193A (en) | Pharmaceutical composition | |
IL56577A0 (en) | Pharmaceutical compositions comprising certain pyrrolidinederivatives | |
GB2021409B (en) | Pharmaceutical composition | |
GB2002229B (en) | Pharmaceutical composition | |
JPS5394038A (en) | Pharmaceutical composition | |
GB2034587B (en) | Pharmaceutical compositions | |
ZA796896B (en) | Pharmaceutical composition having antitumor activity | |
IL54220A0 (en) | Pharmaceutical compositions comprising trans-broparestrol | |
GB2039218B (en) | Pharmaceutical compositions | |
GB2031727B (en) | Pharmaceutical compositions | |
JPS54154516A (en) | Pharmaceutical composition | |
JPS53101520A (en) | Pharmaceutical composition | |
JPS5527168A (en) | Drug composition | |
JPS5386039A (en) | Pharmaceutical composition having antiitumor activity | |
JPS545045A (en) | Pharmaceutical composition |